AZTR Azitra, Inc.

BEARISH Impact: 6/10 S-1
Horizon weeks Filed May 21, 2026 Processed 28d 10h ago SEC 0001493152-26-024849
IPO registration
Latest settled — T+5d
AZTR ▲ +9.80% at T+5d
SHORT call ✗ call lost -9.80% · α vs SPY -8.15% · entry $0.2040 → $0.2240
Next anchor: T+20d in 3d
Last close $0.2030 (close Jun 17) · +0.49% from $0.2040 entry (call sign-flipped)
Entry anchored
May 21, 2026
via day open
T+1d
+2.94%
call -2.94% · α -2.36%
$0.2100
settled 28d ago
T+5d
+9.80%
call -9.80% · α -8.15%
$0.2240
settled 21d ago
T+20d
call — · α —
in 3d
T+60d
call — · α —
in 8w

Executive Summary

Azitra filed an S-1 registration for the resale of up to 255.7 million shares (526% of outstanding) held by selling stockholders from a March 2026 private placement. The company is not selling shares and will not receive proceeds unless warrants are exercised for cash (up to ~$21M). With a going concern opinion, $2.0M working capital, and only 9 months of cash runway, massive potential dilution and ongoing NYSE non-compliance create severe downward pressure on the stock.

Actionable Insight

Expect persistent selling pressure as selling stockholders can immediately resell shares; monitor for stockholder approval of share increase and conversion of preferred stock, which would trigger further dilution. The stock may trade near or below $0.10 as supply overwhelms demand.

Key Facts

  • Registration covers resale of up to 255,699,381 shares, representing 526% of the 16,192,438 shares outstanding.
  • Auditor's report includes going concern uncertainty due to accumulated deficit and negative cash flows.
  • NYSE American has accepted a compliance plan with an April 2027 deadline to cure non-compliance.
  • Company had $5.0M total assets and $2.0M working capital as of December 31, 2025.
  • If all warrants are exercised for cash, Azitra could receive up to ~$21M in gross proceeds.

Financial Impact

Potential dilution of 526% to 1,680% depending on warrant exercise; cash proceeds of $0 to ~$21M if warrants are exercised.

dilutioncash positiongoing concern

Risk Factors

  • Immediate and severe dilution from resale of registered shares
  • Going concern risk with only nine months of cash runway
  • Potential delisting from NYSE American if compliance plan fails
  • No new capital raised from this registration unless warrants are exercised

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
S-1 Filing (Primary)0001493152-26-024849
Exhibit: ex107.htm0001493152-26-024849
Exhibit: ex5-1.htm0001493152-26-024849
Exhibit: ex23-2.htm0001493152-26-024849
Document: 0001493152-26-024849-index-headers.html0001493152-26-024849
Document: 0001493152-26-024849-index.html0001493152-26-024849
Document: 0001493152-26-024849.txt0001493152-26-024849
4 reports for AZTR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AZTR — sortable, filterable
Type Now
Jun 17, 2026
1d ago
8-K
MIXED ★ 5/10
$0.2030 $0.1717▼ −15.42%▼ −16.20%$0.2030 (−0.00%)
Jun 3, 2026
16d ago
EFFECT
BEARISH ★ 7/10
$0.2240 $0.2180▲ +2.68%▲ +3.08%$0.2030 (+9.38%)
May 21, 2026
28d ago
S-1
BEARISH ★ 6/10
$0.2040 $0.2100▼ −2.94%▼ −2.36%$0.2030 (+0.49%)
Mar 5, 2026
15w ago
8-K
NEUTRAL ★ 4/10
$0.1800 $0.2030▲ +12.78%▲ +11.93%$0.2030 (+12.78%)
Showing 4 of 4

US Market Status

Market Closed — Juneteenth — Opens Mon (77h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access